Natural Intelligence Cancer Prevention Project

​Rigvir Group has signed a licence agreement with a UK-based company Smart Nanovirus Limited on a fundamentally new approach to cancer prevention, that would allow to identify high cancer risks timely and address them effectively, using the oncolytic virus Rigvir.

Arrow Down Icon

​Rigvir Group has signed a licence agreement with a UK-based company Smart Nanovirus Limited on a fundamentally new approach to cancer prevention, that would allow to identify high cancer risks timely and address them effectively, using the oncolytic virus Rigvir.

Henceforth, the Rigvir virus is going to be developed also in the non-medical field which could provide preventive help to people with high cancer-risks or scientifically proven cancer presence in the body even before cancer can be diagnosed.

It is known that Rigvir virus is successfully used in cancer treatment and prevention of metastasis in cancer patients. Rigvir virus possesses natural intelligence – the ability to independently seek and destroy circulating tumour cells in the human body, activate the immune system response against cancer and selectively kill cancer cells without affecting healthy cells.

Cancer prevention is insufficiently developed in the medical field; we all know it, and many international organisations point to it too. According to the World Health Organisation (WHO), one in 5 men and one in 6 women worldwide develops cancer during their lifetime.¹ The only cancer prevention today according to the WHO² is the recommendation to change lifestyle. There is no registered target cancer prevention supplement in the market with a serious medical and scientific background.

Today, we have access to unique novelty technologies or early warning solutions that allow scientifically to identify cancer presence before cancer starts to develop and clinical symptoms show up, for example, by detecting circulating tumour cells in the human body. Sadly, modern medicine is unable to properly respond to such technology challenges. The next generation medications are mostly intended for late stages only; and a number of international cancer treatment guidelines recommend observation to early stages.

Also, modern medicine underestimates digital solutions that can speed-up significantly prevention and treatment process and often help save time as well as money – in many cases of such great importance to successfully battle cancer.

We are sure that a combination of the mentioned technologies in synergy with Rigvir virus can change the paradigm of oncology by offering a real and effective solution to eradicate cancer problem at the root.

More information on the Natural Intelligence Cancer Prevention Project: www.smartnanovirus.com.

1 https://www.who.int/cancer/PRGlobocanFinal.pdf
2 https://www.who.int/health-topics/cancer